Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8236894 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 8 Pages |
Abstract
The HDR brachytherapy of a single implant with two fractions plus EBRT is effective in treating patients with localized hormone-naive prostate cancer, with the least genitourinary and gastrointestinal toxicities; however, longer median BF-FCR follow-up is required to assess these findings.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Morio M.D., Takashi M.D., Shintaro M.D., Kazushi M.D., Takeshi M.D., Isao M.D.,